Fixed dose drug combinations - are they pharmacoeconomically sound? Findings and implications especially for lower and middle income countries

Godman, B., McCabe, H., Leong, T., Mueller, D., Martin, A. P., Hoxha, I., Mwita, J. C., Rwegerera, G. M., Massele, A., de Oliveira Costa, J., Nascimento, R. C. R. M. D., Lovato Pires de Lemos, L., Tachkov, K., Milushewa, P., Patrick, O., Niba, L. L., Laius, O., Sefah, I., Abdulsalim, S., Soleymani, F. & 35 others, Guantai, A. N., Achieng, L., Oluka, M., Jakupi, A., Logviss, K., Hassali, M. A., Kibuule, D., Kalemeera, F., Mubita, M., Fadare, J., Ogunleye, O. O., Saleem, Z., Hussain, S., Bochenek, T., Mardare, I., Markovic-Pekovic, V., Alrasheedy, A. A., Fürst, J., Tomek, D., Rampamba, E. M., Alfadl, A., Amu, A. A., Matsebula, Z., Phuong, T. N. T., Thanh, B. N., Kalungia, A., Zaranyika, T., Masuka, N., Olaru, I. D., Wale, J., Hill, R., Kurdi, A., Timoney, A., Campbell, S. & Meyer, J. C., 13 Apr 2020, In: Expert Review of Pharmacoeconomics and Outcomes Research. 20, 1, p. 1-26 26 p.

Research output: Contribution to journal › Article › peer-review